Wutah dodolan YoY sajrone rolas wulan kepungkur: biolifesolutions.com (BLFS)
BioLife Solutions, Inc. (BLFS) is implementing AI and robotic lines for product sterilization and packaging. This chart of the rolling 12-month YoY revenue growth demonstrates the adaptability of the business model, where 0.20 reflects the current value of the metric. The issuer serves as a key link in gene therapy supply chains, focusing on high-margin CryoStor media and the development of logistics solutions.
Ringkesan rincian data analitis BioLife (BLFS)
- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi bursa perusahaan:
- rincian valuasi buku bisnis:
- indikator total utang lan likuiditas perusahaan:
Koefisien Total Utang marang Modal BioLife Solutions, Inc.|BLFS - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal BioLife Solutions Inc|BLFS - Utang perusahaan|Rasio utang marang nilai buku BioLife Solutions Inc|BLFS - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak BioLife Solutions|Rasio jangkoan perantara biolifesolutions.com
- data bathi bisnis lan rasio investasi:
BLFS - Bathi resik|Prakiraan bathi perusahaan BioLife Solutions, Inc.|BLFS - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep BioLife Solutions, Inc.|BLFS - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan BioLife Corp|BLFS - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan BioLife Solutions|BLFS - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan biolifesolutions.com|BLFS - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BioLife Solutions, Inc.
- indikator dodolan lan pendapatan:
Analisis kabeh metrik perusahaan:BioLife - BLFS
BioLife Solutions, Inc. (BLFS) maintains resilience against external shocks by delegating raw material procurement to reliable partners, which minimizes operational risks during scaling. By analyzing the year-over-year sales volume growth trajectory over the TTM, an investor assesses the percentage change in revenue over 12 months to determine the pace of business expansion and timely identify the fading of the asset's primary revenue drivers.
Pesaing BioLife Solutions, Inc. (BLFS)
Wutah pendapatan taunan sajrone rolas wulan kepungkur Tempus AI, Inc (TEM)|QGEN: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Ionis Pharmaceuticals (IONS) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Repligen (RGEN) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur Avidity Biosciences, Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur CRISPR Therapeutics|WGS - Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) RARE|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur BEAM|Wutah dodolan YoY (TTM) SRPT (Sarepta Corp)|TWST - Wutah pendapatan YoY sajrone 12 wulan kepungkur|TXG: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Intellia Therapeutics|STOK: Wutah dodolan YoY (TTM)|WVE - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur MAZE|Wutah pendapatan YoY sajrone 12 wulan kepungkur Sionna Therapeutics, Inc. (SION)|Wutah pendapatan YoY sajrone 12 wulan kepungkur PRME (Prime Medicine Bio)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Taysha|uniQure Pharma - Wutah pendapatan YoY sajrone 12 wulan kepungkur|MeiraGTx Holdings plc - Wutah dodolan YoY sajrone rolas wulan kepungkur|regenxbio.com - Wutah dodolan YoY (TTM)|Solid Bio (SLDB) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|OCGN: Wutah dodolan YoY (TTM)|Wutah pendapatan YoY sajrone 12 wulan kepungkur Pacific Biosciences of California|BNTC (Benitec Biopharma Inc.) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone 12 wulan kepungkur DSGN (Design Therapeutics)|Wutah dodolan YoY (TTM) RCKT|Wutah dodolan YoY sajrone rolas wulan kepungkur FDMT (4D Molecular Therapeutics Inc)|Wutah dodolan YoY (TTM) LXEO (Lexeo Therapeutics Inc.)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur KRRO|EDIT - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur Silence Therapeutics SLN|ProQR Therapeutics NV (PRQR) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Codexis Inc - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Sangamo BioSciences|Wutah dodolan YoY sajrone 12 wulan kepungkur NAUT (Nautilus Biotechnology)|Wutah dodolan YoY sajrone rolas wulan kepungkur metagenomi.co (MGX)|DTIL: Wutah dodolan taun lumaku|Wutah dodolan YoY sajrone rolas wulan kepungkur Generation Bio Co. GBIO|BOLD: Wutah dodolan YoY sajrone 12 wulan kepungkur|XCUR: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Imunon (IMNN) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|PHIO (RXi Pharmaceuticals) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|MBIO (Mustang Bio Inc) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur TransCode Therapeutics, Inc.|Wutah dodolan YoY (TTM) bionanogenomics.com|Wutah dodolan YoY (TTM) APDN|Wutah dodolan YoY sajrone rolas wulan kepungkur BLUE (Bluebird Bio)|Wutah dodolan YoY sajrone rolas wulan kepungkur ImmunoPrecise Antibodies Ltd. IPA|Dinamika pendapatan YoY sajrone rolas wulan kepungkur OMGA|singulargenomics.com - Wutah dodolan YoY (TTM)|Regulus Therapeutics Inc. - Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur|SYRS: Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone 12 wulan kepungkur TBIO|TCON (TRACON Pharmaceuticals) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone 12 wulan kepungkur UBX (unitybiotechnology.com)
